Skip to Content

Find Comparable Stocks for Becton, Dickinson and Company

Becton, Dickinson and Company

BDX - NYQ
Life Sciences
Surgical & Medical Instruments & Apparatus
Country
USA
Market Cap
$65.9B
Dividend Yield
2%
Beta
0.38 (No Correlation)
Trading Volume
1.4M (Moderate)
Momentum
Very Weak Weak Very Strong
Value vs. Growth
Deep Value Fair Value Rapid Growth
Quality
Poor Good Excellent
Size
Micro Large Mega Cap

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

Valuation
Financials
Momentum
Analyst Ratings
Trailing P/E
38.58
Forward P/E
16.08
PEG Ratio
1.03
Price/Book
2.57
EV/EBITDA
17.04
EV/Revenue
4.01

Income Statement

Revenue (TTM)
$20.6B
Gross Profit (TTM)
$9.6B
EBITDA
$5.5B

Financial Ratios

Profit Margin
8%
Operating Margin (TTM)
15%
Gross Profit Margin
46%
EBITDA Margin
27%
ROE (TTM)
7%
ROA (TTM)
4%

Growth

Quarterly Revenue Growth (YoY)
10%
Quarterly Earnings Growth (YoY)
8%
52-Week Range
$216.83
$229.54
$251.99
50-Day Moving Average
$232.70
Price vs. 50-Day MA
-1.36%
200-Day Moving Average
$233.02
Price vs. 200-Day MA
-1.49%
Analyst Ratings Distribution
0
0
3
9
6
Strong Sell Strong Buy
Median Price Target
$276.77
Price to Target
83%

Abbott Laboratories

ABT - NYQ
View ABT's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Life Sciences
Pharmaceutical Preparations
Market Cap: $233.1B
Volume: 6.6M (Moderate)
Beta: 0.69 (Low)
Dividend Yield: 2%
Strong Momentum
Fair Value
Good Quality
Mega Cap

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Compare
Valuation
Financials
Momentum
Ratings

Abbott Laboratories is a global healthcare company that develops medical devices and diagnostics, making it a direct competitor in the life sciences sector similar to BD.

correlation
A

correlation

Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 49%

R-squared: 24%

This indicates a weak positive relationship between the price movements of these stocks.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 3
  • ABT in BDX's comparables: Yes
  • BDX in ABT's comparables: No

A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

financials
B+

financials

Compares key financial metrics to assess operational similarity and financial health.

  • Revenue Growth: 7% vs 10%
  • Profit Margin: 32% vs 8%
  • ROE: 31% vs 7%
  • Operating Margin: 19% vs 15%
  • Revenue (TTM): $41.9B vs $20.6B

A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.

size
A

size

Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.

Market Cap: $233.1B vs $65.9B

Size Category: Mega Cap vs Large Cap

A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.

valuation
A-

valuation

Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 17.59 vs 38.58
  • P/B Ratio: 5.01 vs 2.57
  • EV/EBITDA: 22.77 vs 17.04
  • Forward P/E: 26.74 vs 16.08
  • PEG Ratio: 2.47 vs 1.03

A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

sector
A+

sector

Compares the sector and industry classification of both companies, allowing for partial matches.

  • Sector: LIFE SCIENCES vs LIFE SCIENCES
  • Industry: PHARMACEUTICAL PREPARATIONS vs SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.

analyst ratings
A+

analyst ratings

Compares the consensus of analyst opinions on both stocks.

  • ABT Rating: Buy
  • BDX Rating: Buy

A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.

geo
A+

geo

Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.

  • ABT Country: USA
  • BDX Country: USA
  • Currency: USD vs USD
  • Exchange: NYQ vs NYQ

A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

volatility
A-

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • ABT Beta: 0.69 (Low)
  • BDX Beta: 0.38 (No Correlation)

A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

business similarity
A

business similarity

Assesses the similarity of the companies' business models, products, and services.

This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.

A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • ABT Price vs 200-day MA: 117.70%
  • BDX Price vs 200-day MA: 98.51%

A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • ABT Dividend Yield: 2%
  • BDX Dividend Yield: 2%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

Trailing P/E
18.02
Forward P/E
26.74
PEG Ratio
2.47
Price/Book
5.01
EV/EBITDA
22.77
EV/Revenue
5.86

Income Statement

Revenue (TTM)
$41.9B
Gross Profit (TTM)
$23.3B
EBITDA
$10.7B

Financial Ratios

Profit Margin
32%
Operating Margin (TTM)
19%
Gross Profit Margin
N/A
EBITDA Margin
N/A
ROE (TTM)
31%
ROA (TTM)
6%

Growth

Quarterly Revenue Growth (YoY)
7%
Quarterly Earnings Growth (YoY)
479%
52-Week Range
$98.72
$134.40
$141.23
50-Day Moving Average
$124.20
Price vs. 50-Day MA
8.21%
200-Day Moving Average
$114.19
Price vs. 200-Day MA
17.70%
Analyst Ratings Distribution
1
0
5
13
8
Strong Sell Strong Buy
Median Price Target
$135.54
Price to Target
99%

Medtronic plc

MDT - NYQ
View MDT's Comps
A+
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Life Sciences
Electromedical & Electrotherapeutic Apparatus
Market Cap: $119.4B
Volume: 5.3M (Moderate)
Beta: 0.82 (Low)
Dividend Yield: 3%
Neutral Momentum
Fair Value
Average Quality
Large Cap

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Compare
Valuation
Financials
Momentum
Ratings

Medtronic PLC is a leading medical technology company that focuses on surgical instruments and medical devices, positioning it closely alongside Becton, Dickinson in the industry.

correlation
B

correlation

Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 32%

R-squared: 10%

This indicates a weak positive relationship between the price movements of these stocks.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 6
  • BDX in MDT's comparables: Yes
  • MDT in BDX's comparables: Yes

A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

financials
A-

financials

Compares key financial metrics to assess operational similarity and financial health.

  • Revenue Growth: 10% vs 3%
  • Profit Margin: 8% vs 13%
  • ROE: 7% vs 8%
  • Operating Margin: 15% vs 22%
  • Revenue (TTM): $20.6B vs $33.2B

A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.

size
A+

size

Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.

Market Cap: $65.9B vs $119.4B

Size Category: Large Cap vs Large Cap

A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.

valuation
A+

valuation

Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 38.58 vs 28.39
  • P/B Ratio: 2.57 vs 2.42
  • EV/EBITDA: 17.04 vs 15.95
  • Forward P/E: 16.08 vs 15.92
  • PEG Ratio: 1.03 vs 1.89

A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

sector
A+

sector

Compares the sector and industry classification of both companies, allowing for partial matches.

  • Sector: LIFE SCIENCES vs LIFE SCIENCES
  • Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS vs ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.

analyst ratings
A+

analyst ratings

Compares the consensus of analyst opinions on both stocks.

  • BDX Rating: Buy
  • MDT Rating: Hold

A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.

geo
A+

geo

Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.

  • BDX Country: USA
  • MDT Country: USA
  • Currency: USD vs USD
  • Exchange: NYQ vs NYQ

A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

volatility
B+

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • BDX Beta: 0.38 (No Correlation)
  • MDT Beta: 0.82 (Low)

A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

business similarity
A

business similarity

Assesses the similarity of the companies' business models, products, and services.

This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.

A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • BDX Price vs 200-day MA: 98.51%
  • MDT Price vs 200-day MA: 108.86%

A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • BDX Dividend Yield: 2%
  • MDT Dividend Yield: 3%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

Trailing P/E
28.68
Forward P/E
15.92
PEG Ratio
1.89
Price/Book
2.42
EV/EBITDA
15.95
EV/Revenue
4.16

Income Statement

Revenue (TTM)
$33.2B
Gross Profit (TTM)
$21.8B
EBITDA
$9.4B

Financial Ratios

Profit Margin
13%
Operating Margin (TTM)
22%
Gross Profit Margin
N/A
EBITDA Margin
N/A
ROE (TTM)
8%
ROA (TTM)
5%

Growth

Quarterly Revenue Growth (YoY)
3%
Quarterly Earnings Growth (YoY)
2%
52-Week Range
$74.72
$93.13
$95.57
50-Day Moving Average
$87.42
Price vs. 50-Day MA
6.53%
200-Day Moving Average
$85.55
Price vs. 200-Day MA
8.86%
Analyst Ratings Distribution
1
1
15
10
4
Strong Sell Strong Buy
Median Price Target
$97.05
Price to Target
96%

Thermo Fisher Scientific Inc.

TMO - NYQ
View TMO's Comps
A
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Life Sciences
Measuring & Controlling Devices, Nec
Market Cap: $200.6B
Volume: 1.4M (Moderate)
Beta: 0.79 (Low)
Dividend Yield: 0%
Weak Momentum
Fair Value
Good Quality
Mega Cap

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

Compare
Valuation
Financials
Momentum
Ratings

Thermo Fisher Scientific provides a range of medical instruments and laboratory services, making it relevant in the life sciences and medical technology market comparable to BDX.

correlation
B+

correlation

Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 38%

R-squared: 14%

This indicates a weak positive relationship between the price movements of these stocks.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 5
  • BDX in TMO's comparables: No
  • TMO in BDX's comparables: Yes

A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

financials
A-

financials

Compares key financial metrics to assess operational similarity and financial health.

  • Revenue Growth: 10% vs 5%
  • Profit Margin: 8% vs 15%
  • ROE: 7% vs 13%
  • Operating Margin: 15% vs 19%
  • Revenue (TTM): $20.6B vs $42.9B

A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.

size
A+

size

Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.

Market Cap: $65.9B vs $200.6B

Size Category: Large Cap vs Mega Cap

A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.

valuation
A+

valuation

Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 38.58 vs 32.15
  • P/B Ratio: 2.57 vs 4.05
  • EV/EBITDA: 17.04 vs 19.62
  • Forward P/E: 16.08 vs 22.83
  • PEG Ratio: 1.03 vs 2.06

A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

sector
A+

sector

Compares the sector and industry classification of both companies, allowing for partial matches.

  • Sector: LIFE SCIENCES vs LIFE SCIENCES
  • Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS vs MEASURING & CONTROLLING DEVICES, NEC

A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.

analyst ratings
A+

analyst ratings

Compares the consensus of analyst opinions on both stocks.

  • BDX Rating: Buy
  • TMO Rating: Buy

A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.

geo
A+

geo

Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.

  • BDX Country: USA
  • TMO Country: USA
  • Currency: USD vs USD
  • Exchange: NYQ vs NYQ

A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

volatility
B+

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • BDX Beta: 0.38 (No Correlation)
  • TMO Beta: 0.79 (Low)

A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

business similarity
A

business similarity

Assesses the similarity of the companies' business models, products, and services.

This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.

A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • BDX Price vs 200-day MA: 98.51%
  • TMO Price vs 200-day MA: 93.82%

A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

dividend
B+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • BDX Dividend Yield: 2%
  • TMO Dividend Yield: 0%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

Trailing P/E
32.15
Forward P/E
22.83
PEG Ratio
2.06
Price/Book
4.05
EV/EBITDA
19.62
EV/Revenue
5.28

Income Statement

Revenue (TTM)
$42.9B
Gross Profit (TTM)
$17.7B
EBITDA
$10.8B

Financial Ratios

Profit Margin
15%
Operating Margin (TTM)
19%
Gross Profit Margin
N/A
EBITDA Margin
N/A
ROE (TTM)
13%
ROA (TTM)
5%

Growth

Quarterly Revenue Growth (YoY)
5%
Quarterly Earnings Growth (YoY)
14%
52-Week Range
$492.93
$531.71
$627.02
50-Day Moving Average
$548.09
Price vs. 50-Day MA
-2.99%
200-Day Moving Average
$566.71
Price vs. 200-Day MA
-6.18%
Analyst Ratings Distribution
0
0
6
18
8
Strong Sell Strong Buy
Median Price Target
$661.02
Price to Target
80%

ResMed Inc.

RMD - NYQ
View RMD's Comps
A
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Life Sciences
Surgical & Medical Instruments & Apparatus
Market Cap: $34.1B
Volume: 908.1K (Low)
Beta: 0.74 (Low)
Dividend Yield: 1%
Neutral Momentum
Fair Value
Good Quality
Large Cap

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Compare
Valuation
Financials
Momentum
Ratings

ResMed Inc. is involved in developing medical devices related to sleep and respiratory care, offering a comparison within the medical technology sector.

correlation
B-

correlation

Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 20%

R-squared: 4%

This indicates a negligible relationship between the price movements of these stocks.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 4
  • BDX in RMD's comparables: No
  • RMD in BDX's comparables: Yes

A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

financials
B+

financials

Compares key financial metrics to assess operational similarity and financial health.

  • Revenue Growth: 10% vs 10%
  • Profit Margin: 8% vs 25%
  • ROE: 7% vs 26%
  • Operating Margin: 15% vs 33%
  • Revenue (TTM): $20.6B vs $4.9B

A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.

size
A+

size

Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.

Market Cap: $65.9B vs $34.1B

Size Category: Large Cap vs Large Cap

A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.

valuation
A+

valuation

Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 38.58 vs 27.48
  • P/B Ratio: 2.57 vs 6.50
  • EV/EBITDA: 17.04 vs 20.20
  • Forward P/E: 16.08 vs 22.68
  • PEG Ratio: 1.03 vs 1.51

A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

sector
A+

sector

Compares the sector and industry classification of both companies, allowing for partial matches.

  • Sector: LIFE SCIENCES vs LIFE SCIENCES
  • Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS vs SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.

analyst ratings
A+

analyst ratings

Compares the consensus of analyst opinions on both stocks.

  • BDX Rating: Buy
  • RMD Rating: Buy

A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.

geo
A+

geo

Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.

  • BDX Country: USA
  • RMD Country: USA
  • Currency: USD vs USD
  • Exchange: NYQ vs NYQ

A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

volatility
A-

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • BDX Beta: 0.38 (No Correlation)
  • RMD Beta: 0.74 (Low)

A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

business similarity
A+

business similarity

Assesses the similarity of the companies' business models, products, and services.

This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.

A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • BDX Price vs 200-day MA: 98.51%
  • RMD Price vs 200-day MA: 101.18%

A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • BDX Dividend Yield: 2%
  • RMD Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

Trailing P/E
27.48
Forward P/E
22.68
PEG Ratio
1.51
Price/Book
6.50
EV/EBITDA
20.20
EV/Revenue
6.99

Income Statement

Revenue (TTM)
$4.9B
Gross Profit (TTM)
$2.9B
EBITDA
$1.7B

Financial Ratios

Profit Margin
25%
Operating Margin (TTM)
33%
Gross Profit Margin
N/A
EBITDA Margin
N/A
ROE (TTM)
26%
ROA (TTM)
14%

Growth

Quarterly Revenue Growth (YoY)
10%
Quarterly Earnings Growth (YoY)
65%
52-Week Range
$170.64
$232.44
$262.46
50-Day Moving Average
$236.59
Price vs. 50-Day MA
-1.75%
200-Day Moving Average
$229.74
Price vs. 200-Day MA
1.18%
Analyst Ratings Distribution
0
1
7
7
3
Strong Sell Strong Buy
Median Price Target
$269.38
Price to Target
86%

Stryker Corporation

SYK - NYQ
View SYK's Comps
A
TaxGhost's "TG Grade" is calculated from 100+ datapoints including fundamental metrics, factors, country, correlation, sub-sector, and more.
Life Sciences
Surgical & Medical Instruments & Apparatus
Market Cap: $144.7B
Volume: 2.0M (Moderate)
Beta: 0.96 (Average)
Dividend Yield: 1%
Neutral Momentum
Growth
Good Quality
Large Cap

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.

Compare
Valuation
Financials
Momentum
Ratings

Stryker Corporation specializes in medical devices and surgical equipment, which aligns with BD’s focus on medical instruments and healthcare solutions.

correlation
B

correlation

Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.

Pearson Correlation: 26%

R-squared: 7%

This indicates a negligible relationship between the price movements of these stocks.

network
A+

network

Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.

  • Common comparables: 5
  • BDX in SYK's comparables: No
  • SYK in BDX's comparables: Yes

A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.

financials
A

financials

Compares key financial metrics to assess operational similarity and financial health.

  • Revenue Growth: 10% vs 11%
  • Profit Margin: 8% vs 13%
  • ROE: 7% vs 15%
  • Operating Margin: 15% vs 26%
  • Revenue (TTM): $20.6B vs $22.6B

A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.

size
A+

size

Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.

Market Cap: $65.9B vs $144.7B

Size Category: Large Cap vs Large Cap

A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.

valuation
B

valuation

Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.

  • P/E Ratio: 38.58 vs 48.75
  • P/B Ratio: 2.57 vs 7.07
  • EV/EBITDA: 17.04 vs 27.11
  • Forward P/E: 16.08 vs 28.25
  • PEG Ratio: 1.03 vs 2.82

A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.

sector
A+

sector

Compares the sector and industry classification of both companies, allowing for partial matches.

  • Sector: LIFE SCIENCES vs LIFE SCIENCES
  • Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS vs SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.

analyst ratings
A+

analyst ratings

Compares the consensus of analyst opinions on both stocks.

  • BDX Rating: Buy
  • SYK Rating: Buy

A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.

geo
A+

geo

Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.

  • BDX Country: USA
  • SYK Country: USA
  • Currency: USD vs USD
  • Exchange: NYQ vs NYQ

A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.

volatility
B

volatility

Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.

  • BDX Beta: 0.38 (No Correlation)
  • SYK Beta: 0.96 (Average)

A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.

business similarity
A+

business similarity

Assesses the similarity of the companies' business models, products, and services.

This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.

A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.

momentum
A+

momentum

Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.

  • BDX Price vs 200-day MA: 98.51%
  • SYK Price vs 200-day MA: 104.97%

A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.

dividend
A+

dividend

Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.

  • BDX Dividend Yield: 2%
  • SYK Dividend Yield: 1%

A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.

Select Mutual Comparables:

Trailing P/E
48.75
Forward P/E
28.25
PEG Ratio
2.82
Price/Book
7.07
EV/EBITDA
27.11
EV/Revenue
6.86

Income Statement

Revenue (TTM)
$22.6B
Gross Profit (TTM)
$14.5B
EBITDA
$6.0B

Financial Ratios

Profit Margin
13%
Operating Margin (TTM)
26%
Gross Profit Margin
N/A
EBITDA Margin
N/A
ROE (TTM)
15%
ROA (TTM)
7%

Growth

Quarterly Revenue Growth (YoY)
11%
Quarterly Earnings Growth (YoY)
-53%
52-Week Range
$313.50
$379.30
$406.19
50-Day Moving Average
$382.10
Price vs. 50-Day MA
-0.73%
200-Day Moving Average
$361.35
Price vs. 200-Day MA
4.97%
Analyst Ratings Distribution
0
1
9
13
9
Strong Sell Strong Buy
Median Price Target
$423.36
Price to Target
90%
Toggle between similar stocks and ETFs for comparison.

Loading comparable stocks ...

Abbott Laboratories

ABT - NYQ
A+
$134.40 -3.31 (-2.40%)
Life Sciences
Pharmaceutical Preparations
Market Cap: $233.1B
Volume: 6.6M (Moderate)
Beta: 0.69 (Low)
Dividend Yield: 2%
Strong Momentum
Fair Value
Good Quality
Mega Cap
$134.40
$98.72 $141.23

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace...

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Medtronic plc

MDT - NYQ
A+
$93.13 -0.93 (-0.99%)
Life Sciences
Electromedical & Electrotherapeutic Apparatus
Market Cap: $119.4B
Volume: 5.3M (Moderate)
Beta: 0.82 (Low)
Dividend Yield: 3%
Neutral Momentum
Fair Value
Average Quality
Large Cap
$93.13
$74.72 $95.57

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the...

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Thermo Fisher Scientific Inc.

TMO - NYQ
A
$531.71 +4.07 (0.77%)
Life Sciences
Measuring & Controlling Devices, Nec
Market Cap: $200.6B
Volume: 1.4M (Moderate)
Beta: 0.79 (Low)
Dividend Yield: 0%
Weak Momentum
Fair Value
Good Quality
Mega Cap
$531.71
$492.93 $627.02

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia,...

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.

ResMed Inc.

RMD - NYQ
A
$232.44 +7.41 (3.29%)
Life Sciences
Surgical & Medical Instruments & Apparatus
Market Cap: $34.1B
Volume: 908.1K (Low)
Beta: 0.74 (Low)
Dividend Yield: 1%
Neutral Momentum
Fair Value
Good Quality
Large Cap
$232.44
$170.64 $262.46

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic ob...

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Stryker Corporation

SYK - NYQ
A
$379.30 -3.01 (-0.79%)
Life Sciences
Surgical & Medical Instruments & Apparatus
Market Cap: $144.7B
Volume: 2.0M (Moderate)
Beta: 0.96 (Average)
Dividend Yield: 1%
Neutral Momentum
Growth
Good Quality
Large Cap
$379.30
$313.50 $406.19

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surg...

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.